| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $78.2M | +10.2% |
| Cost of Revenue | $7.2M | -16.2% |
| R&D Expense | $3.9M | -27.3% |
| SG&A Expense | $83.5M | +4.6% |
| Operating Income | -$16.3M | +28.3% |
| Pre-tax Income | -$21.5M | +39.3% |
| Net Income | -$21.5M | +39.3% |
| EPS (Basic) | -$2.12 | -562.5% |
| EPS (Diluted) | -$2.12 | -562.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.5M | +14.7% |
| Accounts Receivable | $26.4M | +32.5% |
| Inventory | $11.5M | +42.4% |
| Current Assets | $125.8M | +19.5% |
| Total Assets | $128.8M | +19.5% |
| Current Liabilities | $162.8M | -7.8% |
| Total Liabilities | $169.1M | -13.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.7M | -117.6% |
| Capital Expenditures | $72K | -78.0% |
| Investing Cash Flow | -$72K | +78.0% |
| Financing Cash Flow | $55.6M | — |
| Free Cash Flow | -$44.8M | -114.5% |
| Stockholders' Equity |
| -$40.4M |
| +53.4% |